I've posted on the different dose sizes used in the mRNA covid vaxes.
Moderna uses a higher dose than Pfizer for all available adult shots, booster or not. See my reply to Jelbea below for explanation of this. With that fact, the latest vax for Omiron has some dose vs effect info:
This is some interesting info on the type of vax that was recently approved in UK. This type combines the original vax with Omicron ba.1. (the strain from last winter)
I made this plot from the press releases both companies had. It shows how much better the new vax is against ba.1 compared to the original one by this measurement. Up to 2X better. It's not a huge improvement, experts are ok with it but not extra impressed vs staying with the old shot. ba.1 is not around anymore but they also claim this UK type shot helps against ba.5.
The reason I looked into this was to see if the dose vs effect continues to hold, and it clearly does. So as has been the case for a while, more is better, at least for "neutralizing titers", (how much useful antibody is created by the shot) It follows that side effects may be more with higher dose, as we often have seen with Mod (50mcg) vs Pfz (30 mcg).
The 60 mcg Pfizer is not likely to be made available, I think it was just part of the trial for them to compare.
In the US we will not see these shots, they are planning a ba.5 type instead. Supposed to be available next month. I hope there can be data for that one like here.